Topics

Veracyte Announces First Quarter 2019 Financial Results

16:15 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Grew Revenue by 47% to $29.5 Million Grew Genomic Test Volume by 33% to 9,162 Tests Company Raises 2019 Annual Revenue Guidance Conference Call and Webcast Today at 5:00 p.m. ET Veracyte, In...

Other Sources for this Article

Investor and Media Contact:
Angie McCabe, 650-243-6371
Vice President, Investor Relations and Corporate Communications
angie@veracyte.com

NEXT ARTICLE

More From BioPortfolio on "Veracyte Announces First Quarter 2019 Financial Results"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...